GlassScriptPhysician profile
Amanda Tobias
NPI 1700537776
$961.30
in general payments reported to CMS, 2019-2025
16 companies · $28.45 in 2025
The $28.45 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $651 · 2023: $258 · 2024: $23.14 · 2025: $28.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $186.45 | 2022 | |
| Impel Pharmaceuticals INC. | $176.78 | 2022-2023 | Trudhesa |
| Sunovion Pharmaceuticals INC. | $122.82 | 2022 | |
| Ucb, INC. | $95.93 | 2022-2023 | Briviact |
| Neurocrine Biosciences, INC. | $68.84 | 2022-2023 | Ongentys, Ingrezza |
| Horizon Therapeutics Plc | $52.83 | 2023 | Uplizna |
| Abbvie INC. | $48.25 | 2022 | |
| Allergan, INC. | $32.53 | 2022 | |
| Sk Life Science, INC. | $30.98 | 2022 | |
| Eisai INC. | $28.45 | 2025 | |
| Biogen, INC. | $26.47 | 2022 | |
| Si-Bone, INC. | $23.14 | 2024 | |
| Supernus Pharmaceuticals, INC. | $19.92 | 2022 | |
| Acadia Pharmaceuticals INC | $19.77 | 2023 | Nuplazid |
| Collegium Pharmaceutical, INC. | $14.95 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Tobias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.